Mark Kieran, MD, PhD

Dr. Kieran is currently the Senior Director, Global Drug Development, Pediatric Oncology, Bristol-Myers Squibb. He received a PhD in Immunology in 1983 from the University of Alberta, Edmonton, Canada, and his MD in 1986 from the University of Calgary. After a post-doctoral fellowship in the Department of Molecular Biology at the Pasteur Institute in Paris, France, he completed a pediatric residency at McGill University in Montreal and a pediatric oncology fellowship at Boston Children’s Hospital. Dr. Kieran was named Director of Pediatric Neuro-Oncology at the Dana-Farber Cancer Institute in 1998 until his move to BMS in 2018. He has focused his career on the development of first in pediatric clinical trials in the areas of targeted therapeutics, gene therapy, anti-angiogenic modalities and immunotherapy. He is currently also on the Medical Staff at Children’s Hospital of Philadelphia.